New findings from programs funded by the Movember Foundation will have considerable impact globally for men diagnosed with prostate cancer.
This research, led by Dr. Robert Bristow of the Princess Margaret Cancer Centre in Toronto, Canada helped develop a genetic test to identify which men are at the highest risk for their prostate cancer to come back after localized treatment with surgery or radiotherapy. These findings for determining the level of severity of prostate cancer have the potential to benefit hundreds of thousands of men globally. This is incredible news for men who have already been diagnosed with prostate cancer, and for the additional 1 in 7 men who are diagnosed annually.
“Our findings set the stage to tackle the ongoing clinical problem of under-treating men with aggressive disease that will recur in 30% to 50% of patients due to hidden, microscopic disease that is already outside the prostate gland during initial treatment.” – Dr. Robert Bristow
For patients who have aggressive prostate cancer, this will now allow doctors to build a more tailored treatment plan. A personalized medicine approach will improve cure rates in patients with aggressive prostate cancer, and also allow doctors to avoid over-treating patients who do not have aggressive forms of the disease.
Canadian researchers will work with other countries to validate the test over the next two to three years in a larger, more diverse group of patients prior to implementation in hospitals worldwide. If validated, this new test for prostate cancer can be turned around in three days and will inform doctors on which patients will need more or less invasive treatments.
This research proves the considerable impact the Movember Foundation is making on the state of men’s health. It’s not too late to help us make a difference. Sign up today and make a donation.
Thank you, Mo Bros, Mo Sistas and donors. Together, we are truly changing the face of men’s health.
Programs we fund
Programs we fund
.com_Carousel.jpg)
